KINTAI Biotech: Epimedium Extract Export Requires Understanding of Certifications

KINTAI Biotech Inc. has released an analysis detailing the certifications and regulations required for the international trade of Epimedium Sagittatum Extract. The company highlights that certifications ensuring product quality and safety are critical for success in the global market, particularly within the health and wellness sectors.

According to the company, understanding mere production figures is insufficient. In international competition, businesses must focus on adhering to high quality and safety standards. KINTAI Biotech has invested in quality control from raw material sourcing to production to ensure its epimedium extract meets global requirements.

The analysis covers key regulations and certification requirements across different regions that impact the import and export of herbal extracts. Its objective is to assist companies in navigating a complex regulatory environment and meeting quality assurance standards.

From KINTAI's perspective, successful export relies on a robust quality management system and supply chain transparency. The company notes that global demand for epimedium extract is rising, but successful exports necessitate meticulous adherence to regulations and quality assurance.